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Cardiovascular disease (CVD) accounts for approx­
imately 30% of deaths worldwide, with 80% of this 
CVD burden occurring in developing countries.[1] The 
epidemiological transition occurring in sub­Saharan 
Africa (SSA) has the consequence of economic and 
social transformation, resulting in dramatic shifts in the disease spectrum 
from communicable diseases and malnutrition to CVD and cancer.[2] 
South Africa (SA) is faced with the challenge of four colliding 
epidemics: (i) poor child and maternal health; (ii) high rates of 
interpersonal violence; (iii) infectious diseases including HIV/AIDS 
and tuberculosis; and (iv) non­communicable diseases (NCDs) 
including CVD. In SA NCDs are prevalent in both rural and urban 
areas, most prominently in poor persons living in urban and peri­
urban settings, resulting in increasing pressure on acute and chronic 
healthcare services.[3] 
A major driver of this NCD burden in SA is the demographic change 
in the country leading to an increase in the proportion of people 
older than 60 years, despite the negative effect of HIV/AIDS on life 
expectancy. Contributions to the CVD burden in the country include 
hypertension, cardiomyopathies, rheumatic valvular heart disease, 
pericardial disease and coronary artery disease, among others.[4] 
In this issue of the journal the clinical approaches to these common 
cardiovascular problems are reviewed, with the dual objective of 
empowering doctors who manage these conditions in primary 
care settings around SA as well as improving the care of CVD in 
primary care settings and emergency departments. This series of 
articles represents the collaborative efforts of primary health/family 
physicians and cardiologists from around the country, who have 
synthesised and presented the most current, evidence­based and 
practical approaches to manage common CVDs. In this edition, the 
important topics of heart failure (HF), dyspnoea, hypertension in 
the young, and valvular heart disease are reviewed. The following 
issue will focus on infective endocarditis, pericardial disease, acute 
coronary syndromes, and chest pain and suspected tachyarrhythmias 
in the emergency room.
HF in SSA is a prevalent problem that presents varying challenges 
in resource­constrained countries, and remains one of the most 
common primary diagnoses for patients on the continent admitted to 
hospital with heart disease. Kraus et al.[5] review the epidemiology of 
HF in SSA and the principles of management, focusing on symptom 
relief, prevention of hospitalisation and improving survival. 
There have been no population­based epidemiological studies on 
HF in Africa, but there have been a number of important hospital­
based studies. The article reviews the classification, aetiology, patho­
physiology and clinical presentation of HF, which represents the final 
common expression of many cardiovascular disorders. While the 
diagnosis of HF is a clinical one, the electrocardiogram (ECG) and 
echocardiogram remain the most useful investigations. 
The authors emphasise the importance of patient education and 
optimisation of medical therapy, especially disease­modifying drugs 
such as angiotensin­converting enzyme inhibitors, beta­blockers and 
those that relieve symptoms and keep patients out of hospital, such 
as digoxin and diuretics. Effective diuresis and complete resolution 
of congestion are key in improving symptoms and functionality of 
patients with HF, along with optimal doses of disease­modifying drugs.
The article by Coccia et al.[6] on dyspnoea reviews the patho­
physiology and management of breathlessness, a complex symptom 
resulting from cardiovascular, respiratory or other system com­
promise. Almost 90% of cases are due to common and easily manage­
able conditions. 
Specifically in SA, with the high burden of HIV infections and 
high prevalence of interpersonal violence, many patients present 
with dyspnoea due to either opportunistic infections related to HIV 
infection or trauma related to violence. A detailed history and careful 
assessment are imperative, looking for specific red flags that suggest a 
life­threatening cause such as hypotension, altered mental status and 
high respiratory rate. The chest radiograph is a useful tool, but has 
low sensitivity in diagnosis of some of the causes. The utility of other 
investigations, such as the ECG, cardiopulmonary exercise testing 
and echocardiography, is concisely discussed. 
Management of dyspnoea should focus primarily on treating the 
underlying disease and relieving symptoms, supported by the use of 
oxygen where indicated, pharmacological therapy and pulmonary 
rehabilitation. Although supplemental oxygen improves mortality 
in chronically hypoxaemic patients with chronic obstructive pulmo­
nary disease, there are conflicting data about its ability to relieve 
breathlessness. As supplemental oxygen is an expensive form of 
therapy, the lack of evidence­based data for this intervention should 
discourage its use. Opioids have been the most widely studied agent 
in the treatment of dyspnoea. Short­term administration reduces 
breathless ness in patients with a variety of conditions. Pulmonary 
rehabilitation is an integral component of the management of patients 
with chronic lung disease, and results in decreased ventilatory require­
ments and respiratory rate during ambulation, thereby decreasing the 
risk of developing dynamic hyperinflation.
Hypertension in the young patient is an important challenge 
for many primary healthcare clinicians. Mangena et al.[7] review 
hyper tension in patients under the age of 40 years. In SA one­third 
of the population (approximately 17 million persons) are hyper­
tensive and in adolescents and young adults (15 ­ 24 years) the 
incidence of hypertension is 10%. The aetiological profile remains 
the same as in the adult population, where 90% of cases are due 
to primary hypertension and the remaining 10% are secondary to 
renal parenchymal and renovascular disease, primary aldosteronism, 
medications such as oral contraceptives, cocaine or amphetamines, 
and rare causes such as coarctation of the aorta. 
The management approach is opportunistic screening for raised 
blood pressure, pharmacotherapy, and alcohol and illicit drug 
cessation. Non­pharmacological approaches to lowering blood 
pressure include weight loss, exercise and avoidance of junk food. 
The SA hypertension guidelines[8] have recently been updated, and 
provide comprehensive guidance on management. Referral of all 
young hypertensives for specialist evaluation is recommended.
Cupido et al.[9] review the diagnosis and management of valvular 
heart disease (VHD), a common but difficult problem in everyday 
clinical practice. Rheumatic heart disease, a sequela of streptococcal 
throat infection, remains a common cause of VHD in SA, and often 
has devastating complications in the young. The causes, clinical 
presentation, and ECG and chest radiographic features of the 
common valve lesions are described. Patients with symptomatic valve 
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lesions should be referred for cardiological specialist assessment. 
In most cases, medical therapy serves as a bridge to definitive 
mechanical or surgical therapy.
Echocardiography with colour flow and Doppler (not focus­
assessed transthoracic echocardiography (FATE) scans) plays a 
pivotal role in confirming the diagnosis and assessing the severity 
of the valve lesions and concomitant pulmonary hypertension, other 
valve lesions and haemodynamic consequences. Invasive testing with 
cardiac catheterisation is reserved for patients in whom there is a 
discrepancy between clinical findings and echocardiography.
Prosthetic valves are also discussed, including properties of the different 
types, and the role and management of anticoagulation in patients with 
VHD. Warfarin is the anticoagulant of choice in patients with metallic 
prosthetic valves, aiming for an international normalised ratio of 2.5 ­ 3.5. 
Antiplatelet agents such as aspirin do not provide adequate protection and 
are not recommended without the use of anticoagulants.
It is our sincere hope that this series of articles on common cardiovascular 
conditions often encountered in primary care settings in SA and SSA will 
improve the care of patients with CVD. Furthermore, it is our wish that 
these articles clearly emphasise the minimum standards for management of 
these common cardiovascular disorders. 
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